title: Electrochemotherapy guided by intraoperative fluorescence imaging for the treatment of inoperable peritoneal micro-metastases.
abstract: Surgery is often the first therapeutic indication in cancer. Patient survival essentially depends on the completeness of tumor resection. This is a major challenge, particularly in patients with peritoneal carcinomatosis (PC), where tumors are widely disseminated in the large peritoneal cavity. These small tumors can be difficult to visualize and are often positioned in delicate locations, further increasing the risk of producing serious tissue/organ damage during their ablation. We propose an innovative therapeutic approach based on intraoperative fluorescence (IF) guided electrochemotherapy (ECT) for the treatment of peritoneal micro-metastases. ECT combines the effects of tissue electro-permeabilization (EP) with the administration of an antimitotic agent (bleomycin) that has poor permeability across intact membranes. IF significantly improves the detection of small tumor lesions. ECT is clinically validated for the treatment of cutaneous tumors in animals and humans, but this is the first time that it has been used along with IF imaging for the targeted treatment of peritoneal metastases in a preclinical model. We set up a murine model of PC that develops secondarily to the resection of a distant primary tumor. Tumor growth and metastasis were finely monitored by non-invasive multimodal imaging (bioluminescence and 3D fluorescence/microCT). Once metastases were detected, mice were randomized into three groups: the ECT group (bleomycin injected intravenously followed by EP) and 2 control groups (bleomycin alone and EP alone). Twenty four hours after the intravenous injection of the tumor targeting agent Angiostamp™700, mice in all groups underwent an abdominal surgery for metastases exploration assisted by fluorescence imaging with the Fluobeam®700 portative device. EP was applied to every nodule detected by IF, except in the bleomycin control group. After surgery, the metastatic invasion was tracked by bioluminescence imaging. In mice treated with bleomycin or EP alone, the metastatic load progressed very rapidly and mice showed no significant difference in lifespan compared to non-operated mice (median lifespan: 27days vs. 25days, respectively). In contrast, the mice treated with ECT displayed a decreased metastatic load and an increased survival rate (median lifespan: 34days). These results provide evidence that IF guided ECT is an effective approach for the treatment of inoperable intraperitoneal micro-metastases.
authors.affiliation: INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France.
authors.forename: V
authors.initials: V
authors.lastname: Josserand
authors.affiliation: INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France.
authors.forename: M
authors.initials: M
authors.lastname: Kéramidas
authors.affiliation: INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France.
authors.forename: J
authors.initials: J
authors.lastname: Lavaud
authors.affiliation: INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France; CHU, Grenoble, France.
authors.forename: C
authors.initials: C
authors.lastname: Righini
authors.affiliation: INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France.
authors.forename: J
authors.initials: J
authors.lastname: Vollaire
authors.affiliation: CNRS, IPBS, Toulouse, France; Université de Toulouse, UPS, IPBS, Toulouse, France.
authors.forename: E
authors.initials: E
authors.lastname: Bellard
authors.affiliation: CNRS, IPBS, Toulouse, France; Université de Toulouse, UPS, IPBS, Toulouse, France.
authors.forename: M P
authors.initials: MP
authors.lastname: Rols
authors.affiliation: CNRS, IPBS, Toulouse, France; Université de Toulouse, UPS, IPBS, Toulouse, France.
authors.forename: J
authors.initials: J
authors.lastname: Teissié
authors.affiliation: INSERM U1209, Institut Albert Bonniot, F-38000 Grenoble, France; Univ. Grenoble Alpes, Institut Albert Bonniot, F-38000 Grenoble, France. Electronic address: jean-luc.coll@ujf-grenoble.fr.
authors.forename: J L
authors.initials: JL
authors.lastname: Coll
authors.affiliation: CNRS, IPBS, Toulouse, France; Université de Toulouse, UPS, IPBS, Toulouse, France. Electronic address: muriel.golzio@ipbs.fr.
authors.forename: M
authors.initials: M
authors.lastname: Golzio
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D045744:Cell Line, Tumor; D053672:Electrochemotherapy; D005260:Female; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008807:Mice, Inbred BALB C; D061848:Optical Imaging; D010534:Peritoneal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D055114:X-Ray Microtomography
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin
keywords: Electrochemotherapy; Electroporation; Fluorescence guided surgery; Optical imaging; Peritoneal metastases; Tumor targeting